These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 36897459)
1. Efficacy and safety of picosecond laser for the treatment of melasma: a systematic review and meta-analysis. Feng J; Shen S; Song X; Xiang W Lasers Med Sci; 2023 Mar; 38(1):84. PubMed ID: 36897459 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial. Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574 [TBL] [Abstract][Full Text] [Related]
3. Laser therapy in the treatment of melasma: a systematic review and meta-analysis. Lai D; Zhou S; Cheng S; Liu H; Cui Y Lasers Med Sci; 2022 Jun; 37(4):2099-2110. PubMed ID: 35122202 [TBL] [Abstract][Full Text] [Related]
4. Fractional 1064 nm Picosecond Laser in Treatment of Melasma and Skin Rejuvenation in Asians, A Prospective Study. Wong CSM; Chan MWM; Shek SYN; Yeung CK; Chan HHL Lasers Surg Med; 2021 Oct; 53(8):1032-1042. PubMed ID: 33544930 [TBL] [Abstract][Full Text] [Related]
5. The role of 755-nm alexandrite picosecond laser in melasma management. Pulumati A; Jaalouk D; Algarin YA; Nouri K Arch Dermatol Res; 2023 Dec; 316(1):60. PubMed ID: 38151661 [TBL] [Abstract][Full Text] [Related]
6. Combination of a 755-nm picosecond laser and hydroquinone 2% cream versus hydroquinone 2% cream alone for the treatment of melasma: A randomized, split-face, and controlled trial. Manuskiatti W; Yan C; Gulfan MCB; Techapichetvanich T; Wanitphakdeedecha R Lasers Surg Med; 2022 Dec; 54(10):1245-1250. PubMed ID: 36345697 [TBL] [Abstract][Full Text] [Related]
7. 755-nm picosecond laser plus topical 20% azelaic acid compared to topical 20% azelaic acid alone for the treatment of melasma: a randomized, split-face and controlled trial. Lai D; Cheng S; Zhou S; Hao J; Chen H; Jia K; Liu H; Cui Y Lasers Med Sci; 2024 Apr; 39(1):113. PubMed ID: 38656631 [TBL] [Abstract][Full Text] [Related]
8. Single and combined 1064 nm Q-switched Nd: YAG laser therapy in melasma: A meta-analysis. Zhang B; Xie B; Shen Y; Zhang L; Song X J Cosmet Dermatol; 2022 Sep; 21(9):3794-3802. PubMed ID: 35876484 [TBL] [Abstract][Full Text] [Related]
9. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma. Ustuner P; Balevi A; Ozdemir M J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378 [TBL] [Abstract][Full Text] [Related]
10. Effects of a fractional picosecond 1,064 nm laser for the treatment of dermal and mixed type melasma. Chalermchai T; Rummaneethorn P J Cosmet Laser Ther; 2018 Jun; 20(3):134-139. PubMed ID: 29020467 [TBL] [Abstract][Full Text] [Related]
11. Melasma treatment with a 1064 nm, picosecond-domain laser with a fractionated multibeam lens array. Bernstein EF; Basilavecchio LD; Wang J Lasers Surg Med; 2023 Nov; 55(9):801-808. PubMed ID: 37668307 [TBL] [Abstract][Full Text] [Related]
12. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Wattanakrai P; Mornchan R; Eimpunth S Dermatol Surg; 2010; 36(1):76-87. PubMed ID: 20298254 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Picosecond Laser in the Treatment of Melasma: A Network Meta-analysis. Ren R; Bao S; Qian W; Zhao H Dermatol Surg; 2023 May; 49(5S):S49-S55. PubMed ID: 37116000 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety Evaluation of Picosecond Alexandrite Laser with a Diffractive Lens Array for Treatment of Melasma in Asian Patients by VISIA Imaging System. Chen YT; Lin ET; Chang CC; Lin BS; Chiang HM; Huang YH; Lin HY; Wang KY; Chang TM Photobiomodul Photomed Laser Surg; 2019 Sep; 37(9):559-566. PubMed ID: 31411549 [No Abstract] [Full Text] [Related]
15. Safety and efficacy of a picosecond 755-nm alexandrite laser combined with topical tranexamic acid in the treatment of melasma. Zhou N; Tao J; Yi Z; Wu L; Liu Z; Yang B J Cosmet Dermatol; 2024 Nov; 23(11):3579-3584. PubMed ID: 39234928 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of laser-assisted delivery of tranexamic acid for the treatment of melasma: a systematic review and meta‑analysis. Feng J; Shen S; Song X; Xiang W J Cosmet Laser Ther; 2022 Nov; 24(6-8):73-79. PubMed ID: 36403155 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy and safety of picosecond Nd:YAG laser (1,064 nm), picosecond alexandrite laser (755 nm) and 2% hydroquinone cream in the treatment of melasma: A randomized, controlled, assessor-blinded trial. Liang S; Shang S; Zhang W; Tan A; Zhou B; Mei X; Li L Front Med (Lausanne); 2023; 10():1132823. PubMed ID: 37056729 [TBL] [Abstract][Full Text] [Related]
18. A prospective, split-face study comparing 1,064-nm picosecond Nd:YAG laser toning with 1,064-nm Q-switched Nd:YAG laser toning in the treatment of melasma. Hong JK; Shin SH; Park SJ; Seo SJ; Park KY J Dermatolog Treat; 2022 Aug; 33(5):2547-2553. PubMed ID: 35067157 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Topical Silymarin Versus Low Fluence 1064-nm Q Switched Nd:YAG Laser in the Treatment of Melasma: A Comparative Randomized Trial. Ibrahim SMA; Farag AS; Ali MS; El-Gendy WMAF Lasers Surg Med; 2021 Dec; 53(10):1341-1347. PubMed ID: 34101206 [TBL] [Abstract][Full Text] [Related]
20. A Prospective, Split-Face, Randomized Study Comparing a 755-nm Picosecond Laser With and Without Diffractive Lens Array in the Treatment of Melasma in Asians. Manuskiatti W; Yan C; Tantrapornpong P; Cembrano KAG; Techapichetvanich T; Wanitphakdeedecha R Lasers Surg Med; 2021 Jan; 53(1):95-103. PubMed ID: 32865858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]